|
|
|
Prostate and Urologic Cancer Program
|
Nearly 25 percent of all solid tumors are cancers that arise in the urinary tract. The Prostate and Urologic Cancer Program at Froedtert & The Medical College of Wisconsin features a complete team of physicians with advanced training in the care and treatment of these diseases.
Urologic cancers can have a significant impact on patients’ functional abilities. The Prostate and Urologic Cancer Program offers exceptional experience in several organ-sparing and function-preserving treatments for urologic malignancies.
|
|
|
Prostate CancerProstate cancer is as common in men as breast cancer is in women. We offer a full range of surgical, radiation, hormone and chemotherapy treatments for men with this disease.
Men who have been diagnosed with prostate cancer are invited to learn more about their condition and explore new options. Find out more about our Prostate Cancer Second Opinion Program.
Bladder and Ureteral CancerCancers of the bladder and ureter require team-based management. Our care team includes reconstructive surgeons who are often able to preserve urinary function for patients who require bladder removal. Our program also offers expertise in drug treatments, minimally invasive ureteral and bladder surgeries, as well as organ preservation techniques for bladder cancers.
Kidney CancerAs imaging technologies become more widespread, more kidney tumors are being detected at an early stage. We offer a full range of techniques for removing tumors, while preserving as much of the organ as possible. In addition, newer targeted chemotherapy agents are available for patients with advanced kidney cancer.
Testicular CancerCancer of the testis is highly treatable. Our care team focuses on developing a treatment plan that achieves a cure while offering a good chance of preserving fertility.
Penile CancerRare penile cancers are essentially skin cancers involving the penis. Our urologic surgeons work in cooperation with dermatologic surgeons and radiation oncologists to treat the cancer while sparing as much healthy tissue as possible.
Cancer Genetics Screening Program
There are several genetic risk factors related to urologic cancers. The Cancer Genetics Screening Program at Froedtert & The Medical College of Wisconsin provides genetic counseling and testing to individuals who may be at increased risk of cancer due to a personal history of cancer, a family history of cancer or an underlying genetic condition. The goal of the program is to provide personalized counseling regarding cancer risk, cancer genetics, genetic testing, early detection, improved cancer management and possible risk reduction. Learn more about the Cancer Genetics Screening Program.
Assisted Reproductive TechnologiesUrologic cancers can impact men and women during their reproductive years. Treatments have the potential to adversely affect fertility. For those patients interested in future fertility, or those attempting to conceive following cancer therapy, the Prostate and Urologic Cancer Program offers a wide range of sophisticated reproductive technologies to assist couples in conception.
Clinical Trials
The clinical trials available through the Prostate and Urologic Cancer Program give our patients access to newest treatment options. Learn more about our clinical trials.
Prostate Cancer (Us Too!) Support GroupThis support group is for men who have been newly diagnosed with prostate cancer and survivors of prostate cancer, as well as men at risk. Spouses, families, significant others and caregivers are also welcome to attend. Visit our calendar of events for more information.
When:
First Thursday of even numbered months
5:30 p.m. - 7:30 p.m.
Where:
Clinical Cancer Center,
Conference Room. M
Source: Dr. William See, Chief of Urologic Surgery (8/10/04) Last Review Date: Jan. 26, 2011 Online Editor(s): Kathryn Adam |
|
|